STVN

MKT CAP:$4B

Stevanato Group S.p.A.

Market Cap

$4B

Healthcare·Medical - Instruments & Supplies·🇮🇹 Italy·NYSE

Healthcare·Medical·🇮🇹·NYSE

Stock Price

$16.18-$4.40 (-21.38%)

Apr 24, 2026

Company Details

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, med...

CEO

Franco Stevanato

IPO Date

Jul 16, 2021

Website

www.stevanatogroup.com

Key Metrics TTM

Revenue

$401M

— YoY

Net Income

$55M

EPS (Diluted)

$0.20

Free Cash Flow

$5M

Revenue / Share

$1.47

Gross Margin

30.9%

Operating Margin

19.2%

Net Margin

13.7%

FCF Margin

1.4%

P/S

10.9x

P/E

79.0x

Earnings Reports

Q1 2026

May 7, 2026

PENDING

FY 2025

Mar 4, 2026

$1.3BEPS $0.57

Q4 2025

Mar 4, 2026

$401MEPS $0.20

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 25	$401M	$124M	$77M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 25	$108M	$5M

Capital Expenditures

Quarter	CapEx
Q4 25	$103M

CapEx

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q4 25	$7M	$40M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$429M	$32M	$461M
Q2 22	$368M	$32M	$400M
Q3 22	$304M	$32M	$336M
Q4 22	$267M	$33M	$300M
Q1 23	$186M	$16M	$202M
Q2 23	$72M	$0	$72M
Q3 23	$76M	$0	$76M
Q4 23	$81M	$875.7K	$82M
Q1 24	$218M	$0	$218M
Q2 24	$91M	$0	$91M
Q3 24	$91M	$0	$91M
Q4 24	$115M	$0	$115M
Q1 25	$106M	$0	$106M
Q2 25	$110M	$0	$110M
Q3 25	$132M	$0	$132M
Q4 25	$153M	$3M	$155M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 25	273M	—	—

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 25	$66.8K	6K

Revenue / Employee